Molecular Diagnostics
Autoantibody Status Guides Treatment in Myasthenia Gravis
Autoantibody status plays a significant role in diagnosis and therapy decisions for myasthenia gravis. EUROIMMUN has developed cell-based indirect immunofluorescence assays based on transfected human cell lines expressing the corresponding target antigens AChR and MuSK. More...20 Dec 2023
ELISA IVD Test Noninvasively Diagnoses Bladder Cancer with Unprecedented Accuracy
A new approach aims to overcome the limitations in early detection and ongoing surveillance of bladder cancer by employing immunoassays that target five unique protein biomarkers exclusive to the disease. More...19 Dec 2023
Gold Member
Turnkey Packaging Solution
HLX
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
In Other News
Next-Gen Esophageal DNA Test Offers Enhanced Assay Performance and Lower Costs
New Sample Preparation Solutions Simplify and Automate Respiratory Diagnostic Testing
Liquid Biopsy Predicts Immunotherapy Response and Toxicity in Advanced Lung Cancer Patients
Biomarker Test Identifies Patients at Risk of Developing AKI within 48-72 Hours in ICU Setting
HPV DNA Test Using Lymphatic Fluid Collected After Surgery Could Predict Risk of Cancer Recurrence
Automated Device for Non-Invasive Measurement of Cells’ Electrical Properties to Advance Cancer Diagnosis
Ultrasensitive Assay Predicts Hodgkin Lymphoma Recurrence and Splits Disease into Two Subgroups
Discovery of Rogue Protein Paves Way for Diagnostic Test to Detect Early-Onset Dementia
Smear Test Detects Aggressive Ovarian Cancer Years before Clinical Diagnosis
Multimodal Liquid Biopsy Approach Integrates ctDNA, CTC and Protein Biomarkers from Single Blood Sample
Simple Blood Test Identifies Organs Likely to Fail First
Blood Test Identifies Individuals at Risk of Developing Parkinson’s Disease Before Symptoms Occur
Pocket-Sized DNA Sequencers Track Malaria Drug Resistance in Near Real-Time
Cell-Based Assays Recommended for Autoantibody Detection in Demyelinating Diseases
AI-Powered Blood Test Proves Highly Accurate in Risk Stratification of Heart Disease Patients
Microfluidic Platform for Rapid Malaria Infection Screening and Genotyping Delivers 98% Accuracy
Oral Gargle Biomarker Panel Provides Earlier Detection of Oropharyngeal Cancer
Blood Tests to Enable Early Identification of Cognitive Decline and Personalized Treatments
Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodules
Low Cost, Portable Molecular Diagnostic Platform Identifies Infectious Diseases with High Accuracy
Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response
High Sensitivity Blood Test Aids Emergency Diagnosis of Heart Conditions
Innovative, Easy-to-Use Molecular Diagnostics Platform Advances Newborn Screening
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.